Filing Details
- Accession Number:
- 0001179110-15-012442
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-20 19:09:46
- Reporting Period:
- 2015-08-18
- Filing Date:
- 2015-08-20
- Accepted Time:
- 2015-08-20 19:09:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286370 | R Michael Minogue | C/O Abiomed, Inc., 22 Cherry Hill Drive Danvers MA 01923 | President, Ceo, Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock $.01 Par Value | Acquisiton | 2015-08-18 | 146,800 | $5.86 | 386,518 | No | 4 | M | Direct | |
| Common Stock $.01 Par Value | Disposition | 2015-08-18 | 38,126 | $105.05 | 348,392 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2015-08-18 | 28,530 | $105.92 | 319,862 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2015-08-18 | 7,214 | $106.77 | 312,648 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2015-08-18 | 523 | $107.48 | 312,125 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2015-08-19 | 13,996 | $102.91 | 298,129 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2015-08-19 | 21,601 | $103.78 | 276,528 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2015-08-19 | 31,210 | $104.73 | 245,318 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2015-08-19 | 5,600 | $105.50 | 239,718 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-08-18 | 146,800 | $0.00 | 0 | $5.86 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-05-28 | 2019-05-28 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock $.01 Par Value | 36,082 | Indirect | By Trust |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $13.57 | 2007-06-01 | 2016-06-01 | 0 | 82,000 | Direct |
| Common Stock | Stock Option (right to buy) | $13.80 | 2009-05-23 | 2018-05-23 | 0 | 28,333 | Direct |
| Common Stock | Stock Option (right to buy) | $18.63 | 2009-06-15 | 2018-08-13 | 0 | 76,875 | Direct |
| Common Stock | Stock Option (right to buy) | $5.86 | 2010-05-28 | 2019-05-28 | 0 | 56,700 | Direct |
| Common Stock | Stock Option (right to buy) | $10.03 | 2011-06-03 | 2020-06-03 | 0 | 105,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $22.44 | 2013-05-22 | 2022-05-22 | 0 | 50,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $23.15 | 2014-05-14 | 2024-05-14 | 0 | 21,250 | Direct |
| Common Stock | Stock Option (right to buy) | $21.55 | 2015-05-14 | 2024-05-14 | 0 | 85,000 | Direct |
| Common Stock | Stock Option (right to buy) | $66.25 | 2016-05-13 | 2025-05-13 | 0 | 35,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2016-06-01 | 0 | 82,000 | Direct |
| 2018-05-23 | 0 | 28,333 | Direct |
| 2018-08-13 | 0 | 76,875 | Direct |
| 2019-05-28 | 0 | 56,700 | Direct |
| 2020-06-03 | 0 | 105,000 | Direct |
| 2022-05-22 | 0 | 50,000 | Direct |
| 2024-05-14 | 0 | 21,250 | Direct |
| 2024-05-14 | 0 | 85,000 | Direct |
| 2025-05-13 | 0 | 35,000 | Direct |
Footnotes
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- These options become exercisable based on the achievement of certain performance milestones.
- These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy shares of Common Stock under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $104.4100 and $105.4000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $105.4100 and $106.4000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $106.4100 and $107.4000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $107.4800 and $107.5150. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $102.3000 and $103.2750. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $103.3100 and $104.3000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $104.3100 and $105.3000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $105.3100 and $105.9000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- These securities are held by the Renee D. Minogue Revocable Trust, Renee D. Minogue, trustee DTD 12/29/2005.
Billionaire Hedge Funds
